Rheinmetall’s Drone Expansion Wagers on Future Growth as Q1 Shortfall Rattles Investors

Rheinmetall launches serial production of FV-014 loitering munition in Neuss, but shares languish near 52-week low after Q1 revenue and profit miss expectations.

Rheinmetall this week fired up serial production of its FV-014 loitering munition in Neuss, a move designed to bolster the company’s credentials as a European leader in autonomous weapon systems. The timing, however, could hardly be more challenging. The stock languishes just 0.72% above its 52-week low of €1,118.00, having shed more than a third of its value over the past twelve months. Investors are demanding proof that the manufacturer can translate its bulging order book into earnings momentum.

The new assembly line in Neuss complements existing drone capacity in Braunschweig. Rheinmetall secured a firm order worth roughly €300 million from the German armed forces, with a framework contract allowing further call-offs in the years ahead. First deliveries are scheduled for 2027. The FV-014 is designed for longer-range precision strikes, using advanced sensor technology to locate and engage targets autonomously. The company views this platform as a cornerstone of its push into the fast-growing market for loitering munitions.

Yet the operational milestone has done little to lift the share out of its technical funk. After closing Friday at €1,123.80, the stock edged up 0.20% to €1,126.00 on Monday — a marginal recovery that masks the scale of the recent rout. Over the past 30 days, Rheinmetall shares have plunged 25.04%; year-to-date the loss stands at 29.69%, and the 12-month decline is a brutal 36.02%. The distance to the 50-day moving average is a negative 21.78%, underscoring the bearish grip on the name.

The immediate cause of the selling pressure is the first-quarter performance. Revenue for the three months to March came in at €1.94 billion, well short of the roughly €2.3 billion analysts had pencilled in. Operating profit of €224 million also missed the consensus mark. Although earnings per share improved from €1.92 to €2.42, free cash flow swung to a negative €285 million, a figure that stung a market already nervous about the heavy capital spending required for capacity expansion.

Several brokerages have responded with rating downgrades. JPMorgan dropped its recommendation to Neutral from Overweight and slashed the price target from €2,130 to €1,500. Berenberg followed suit, cutting its fair value estimate to €1,750. Other houses see the slump as a buying opportunity: Warburg Research upgraded the stock to Buy, citing a much more attractive valuation, while Barclays retains its positive stance and continues to view Rheinmetall as a prime beneficiary of Europe’s long-term rearmament drive.

To steady nerves, members of the management and supervisory boards bought shares in the open market on Monday. Such directors’ dealings can shore up confidence in a weak tape, but they do not substitute for solid operational evidence. The real test will be whether the Neuss facility scales according to plan and whether delivery cash flow starts to materialise after 2027.

Underlying demand remains robust. The geopolitical backdrop continues to fuel orders for advanced munitions, and Rheinmetall is expanding its cruise missile capacity through a joint venture with Dutch firm Destinus. Meanwhile, the German Red Cross is calling for €2 billion in civil protection investments by 2027 — spending that could indirectly generate contracts for security infrastructure. For 2027, analysts project a price-to-earnings ratio of roughly 20 and earnings-per-share growth of around 31%. That bull case hinges on management proving that the high order intake can be converted into widening margins.

For now, the market is pricing execution risk, not future promise. Until the next earnings cycle delivers tangible improvement in free cash flow, Rheinmetall’s stock will likely remain tethered to its recent lows, even as the company rewires its production base for the era of autonomous warfare.